[1]
2024. Real-World Switch Rates of Risankizumab and Other Biologics in Psoriasis Patients With Psoriatic Arthritis. SKIN The Journal of Cutaneous Medicine. 8, 6 (Nov. 2024), s443. DOI:https://doi.org/10.25251/skin.8.supp.443.